A Form 4 filed on September 3, 2026, discloses that Titus B. Ball, Principal Accounting Officer of BeOne Medicines Ltd. (NASDAQ:ONC), disposed of 132 American Depositary Shares on September 1, 2026, under a mandatory tax withholding provision tied to a restricted share unit award vesting.

Key Highlights

  • Reporting person: Titus B. Ball, Principal Accounting Officer of BeOne Medicines Ltd.
  • Transaction: 132 American Depositary Shares disposed of (transaction code S) on September 1, 2026, at $355.86 per share.
  • Purpose of sale: According to the filing, the sale was effected pursuant to a mandatory tax withholding provision in the reporting person's restricted share unit award agreement.
  • Vesting schedule: The filing states that 1/4th of the securities vest on each anniversary of August 31, 2023, subject to continued service.
  • Post-transaction ADS holding: Following the transaction, Ball holds 0 American Depositary Shares directly.
  • Ordinary Shares held: Ball beneficially owns 97,929 Ordinary Shares directly following the reported transaction.
  • ADS conversion ratio: Each American Depositary Share represents 13 Ordinary Shares, according to the filing.

Ball's ADS Disposal at BeOne Medicines Under Tax Withholding Provision

According to the Form 4 filed with the SEC on September 3, 2026, Titus B. Ball, serving as Principal Accounting Officer of BeOne Medicines Ltd., disposed of 132 American Depositary Shares on September 1, 2026. The filing records the transaction under code "S" at a price of $355.86 per share. The filing notes that Ball's address is listed as c/o BeOne Medicines I GmbH, Aeschengraben 27, 21st Floor, Basel, Switzerland.

The filing explains that the disposal was not a discretionary open-market sale. Instead, it states that "the sale was effected pursuant to a mandatory tax withholding provision in the Reporting Person's restricted share unit award agreement in connection with the vesting of a restricted share unit award previously granted to the Reporting Person." The award vests at a rate of 1/4th of the securities on each anniversary of August 31, 2023, subject to continued service, according to the filing.

Following the reported transaction, Ball directly holds 0 American Depositary Shares and 97,929 Ordinary Shares. The filing notes that each American Depositary Share represents 13 Ordinary Shares. The Form 4 was signed by Frank Collazo as Attorney-in-Fact on September 3, 2026, and was filed as a report by one reporting person. The issuer is identified as BeOne Medicines Ltd., trading on NASDAQ:ONC.

What Was Disclosed

BeOne Medicines Ltd.'s Principal Accounting Officer, Titus B. Ball, filed a Form 4 reporting the disposal of 132 American Depositary Shares at $355.86 each on September 1, 2026, under a mandatory tax withholding provision connected to a vesting restricted share unit award.